New York (December 28th, 2012) - Questcor Pharmaceuticals, Inc.(NASDAQ:QCOR) 27.78 -2.12 (-7.09%). Range 27.35 - 29.78. 52 week 17.25 - 58.91. Questcor Pharmaceuticals, Inc. (QCOR) plunged in trade amid reports that Blue Cross Blue Shield had denied coverage of its top-selling drug, Acthar.
Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company’s primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications. As of December 31, 2011, H.P. Acthar Gel was approved for the treatment of acute exacerbations of multiple sclerosis in adults, and as monotherapy for the treatment of infantile spasms in infants and children under two years of age.
Find out if this is the right moment for investors to invest in QCOR by getting the free full report here: http://www.wallstreetscoop.net/market-scan/?symbol=QCORZaZa Energy Corp (NASDAQ:ZAZA) 2.16 -0.17 (-7.30%) . Vermilion Energy Inc has completed, through its wholly owned subsidiaries, the acquisition of ZaZa Energy Corporation's ZaZa Energy France S.A.S. ZaZa Energy France's operating interests cover approximately 24,300 acres with 100% working interests in the Saint Firmin, Chateaurenard, Courtenay, Chuelles, and Charmottes fields in the Paris Basin. Vermilion paid approximately US$76 million cash at closing of the Acquisition, including working capital.
ZaZa Energy Corporation, is a holding company for Toreador Resources Corporation (Toreador) and ZaZa Energy LLC (ZaZa LLC). On February 21, 2012, the Company consummated the combination of Toreador Resources Corporation and ZaZa Energy LLC.
Find out where ZAZA could be headed by getting the free report here:
WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains. WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.Simply sign up for free and start receiving exclusive alerts.Subscribe Here: http://www.WallStreetScoop.netDisclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.Contact Info:Thomas GreeneWall Street Scoopinfo@wallstreetscoop.net347-905-5009